Aaron D. Goldberg

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 20 papers. Top paper: “Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML”.

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Blood Advances(2021)10.1182/bloodadvances.2020003734

N/A

0.787DataRank · unranked

189 citations

Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob L. Glass +14 more

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1966788

N/A

0.574DataRank · unranked

45 citations

Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Josel D. Ruiz +27 more

Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1885664

N/A

0.425DataRank · unranked

16 citations

Varun Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark B. Geyer +7 more

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

Blood Advances(2025)10.1182/bloodadvances.2025018178

N/A

0.357DataRank · unranked

7 citations

Brian Ball, Yasmin Abaza, Jessica K. Altman, Rahul Thakur, Moiez Ali +12 more

HMA/VEN treatment modifications and associated outcomes in IDH -mutant AML

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2411436

N/A

0.165DataRank · unranked

2 citations

Andriy Derkach, Christopher Famulare, Gaurav K. Gupta, P. Dayand Borge, Mark B. Geyer +8 more

Single cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.20.508786

N/A

0DataRank · unranked

6 citations

Robert L. Bowman, Sonali Persaud, Ying Liu, Qi Gao, Jingping Zhang +12 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia: an appraisal of the new WHO and IC classifications and ELN risk stratification

medRxiv(2022)10.1101/2022.12.26.22283876

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

Science Advances(2023)10.1126/sciadv.adg0488

N/A

0DataRank · unranked

48 citations

Robert L. Bowman, Sonali Persaud, Ying Liu, Rosemary Neigenfind, Qi Gao +13 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood Cancer Journal(2024)10.1038/s41408-024-01000-2

N/A

0DataRank · unranked

31 citations

Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg +12 more

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML

Blood Advances(2024)10.1182/bloodadvances.2024012858

N/A

0DataRank · unranked

12 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

American Journal of Hematology(2024)10.1002/ajh.27366

N/A

0DataRank · unranked

9 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia

Blood Neoplasia(2024)10.1016/j.bneo.2024.100038

N/A

0DataRank · unranked

3 citations

Yannis K. Valtis, Andriy Derkach, Meira Yisraeli Salman, Leora Boussi, Jenna Ciervo +7 more

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

Cancer(2025)10.1002/cncr.70024

N/A

0DataRank · unranked

3 citations

Leora Boussi, David Nemirovsky, Andriy Derkach, Jenna Ciervo, Christopher Famulare +12 more

Venetoclax in Combination With Pediatric‐Inspired Chemotherapy in Adults With Newly Diagnosed Acute Lymphoblastic Leukemia: Results of a Phase I Trial

American Journal of Hematology(2025)10.1002/ajh.70082

N/A

0DataRank · unranked

1 citations

David Nemirovsky, Andriy Derkach, I. Cacace, Martina Torres, Colleen Finneran +6 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia

Blood Advances(2023)10.1182/bloodadvances.2023009675

N/A

0DataRank · unranked

19 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.11.089060

N/A

0DataRank · unranked

7 citations

S. Haihua Chu, Aaron D. Goldberg, Salma Parvin, Richard P. Koche, Jacob L. Glass +22 more

Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.011

N/A

0DataRank · unranked

41 citations

Stephanie Lobaugh, Josel D. Ruiz, Parastoo B. Dahi, Aaron D. Goldberg, James W. Young +22 more

The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy

American Journal of Hematology(2021)10.1002/ajh.26146

N/A

0DataRank · unranked

16 citations

Meier Hsu, Sean M. Devlin, Maria E. Arcila, Mikhail Roshal, Yanming Zhang +17 more

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia

American Journal of Hematology(2022)10.1002/ajh.26757

N/A

0DataRank · unranked

25 citations

Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy M. Robinson, Christopher Famulare +35 more